STOCK TITAN

[Form 4] National CineMedia, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Catherine Sullivan, President - Sales & Marketing at National CineMedia (NCMI), sold 734 shares of NCMI common stock on 08/21/2025 at $4.19 per share under a pre-established 10b5-1 trading plan adopted May 22, 2025. After the sale she beneficially owned 23,535 shares. The Form 4 was signed by an attorney-in-fact on 08/25/2025.

Catherine Sullivan, Presidente - Sales & Marketing di National CineMedia (NCMI), ha venduto 734 azioni ordinarie di NCMI il 08/21/2025 a $4.19 per azione nell'ambito di un piano di negoziazione 10b5-1 predefinito adottato il 05/22/2025. Dopo la vendita possedeva beneficiariamente 23,535 azioni. Il Modulo 4 è stato firmato da un procuratore il 08/25/2025.

Catherine Sullivan, President - Sales & Marketing en National CineMedia (NCMI), vendió 734 acciones ordinarias de NCMI el 08/21/2025 a $4.19 por acción bajo un plan de negociación 10b5-1 preestablecido adoptado el 05/22/2025. Tras la venta poseía a título beneficiario 23,535 acciones. El Formulario 4 fue firmado por un apoderado el 08/25/2025.

Catherine Sullivan, President - Sales & Marketing at National CineMedia (NCMI)는 2025/08/21에 사전 설정된 10b5-1 거래계획(2025/05/22 채택)에 따라 NCMI 보통주 734주를 주당 $4.19에 매도했습니다. 매도 후 그녀는 실질적으로 23,535주를 보유하고 있었습니다. Form 4는 2025/08/25에 대리인이 서명했습니다.

Catherine Sullivan, President - Sales & Marketing chez National CineMedia (NCMI), a vendu 734 actions ordinaires NCMI le 08/21/2025 à 4,19 $ l'action dans le cadre d'un plan de négociation 10b5-1 préétabli adopté le 05/22/2025. Après la vente, elle détenait à titre bénéficiaire 23,535 actions. Le Formulaire 4 a été signé par un mandataire le 08/25/2025.

Catherine Sullivan, President - Sales & Marketing bei National CineMedia (NCMI), verkaufte am 08/21/2025 im Rahmen eines vorab festgelegten 10b5-1-Handelsplans, der am 05/22/2025 angenommen wurde, 734 Stammaktien von NCMI zum Preis von $4.19 je Aktie. Nach dem Verkauf war sie wirtschaftlich berechtigt an 23,535 Aktien. Das Formular 4 wurde am 08/25/2025 von einem Bevollmächtigten unterschrieben.

Positive
  • None.
Negative
  • None.

Insights

Insider sale was small and executed under a 10b5-1 plan, suggesting routine liquidity rather than signal of new company information.

The sale of 734 shares at $4.19 represents a modest disposition relative to the remaining 23,535 shares reported beneficially owned. Execution pursuant to a 10b5-1 plan reduces the likelihood the transaction was based on undisclosed material information. For investors, this Form 4 is informational but not materially impactful to the company’s fundamentals.

Use of a documented 10b5-1 plan and attorney-in-fact signature indicates procedural compliance with insider-trading controls.

The filing shows customary governance practices: the reporting person used a written trading plan adopted May 22, 2025, and an authorized representative signed the Form 4. The transaction appears to follow internal and SEC disclosure requirements, providing transparency without revealing new corporate developments.

Catherine Sullivan, Presidente - Sales & Marketing di National CineMedia (NCMI), ha venduto 734 azioni ordinarie di NCMI il 08/21/2025 a $4.19 per azione nell'ambito di un piano di negoziazione 10b5-1 predefinito adottato il 05/22/2025. Dopo la vendita possedeva beneficiariamente 23,535 azioni. Il Modulo 4 è stato firmato da un procuratore il 08/25/2025.

Catherine Sullivan, President - Sales & Marketing en National CineMedia (NCMI), vendió 734 acciones ordinarias de NCMI el 08/21/2025 a $4.19 por acción bajo un plan de negociación 10b5-1 preestablecido adoptado el 05/22/2025. Tras la venta poseía a título beneficiario 23,535 acciones. El Formulario 4 fue firmado por un apoderado el 08/25/2025.

Catherine Sullivan, President - Sales & Marketing at National CineMedia (NCMI)는 2025/08/21에 사전 설정된 10b5-1 거래계획(2025/05/22 채택)에 따라 NCMI 보통주 734주를 주당 $4.19에 매도했습니다. 매도 후 그녀는 실질적으로 23,535주를 보유하고 있었습니다. Form 4는 2025/08/25에 대리인이 서명했습니다.

Catherine Sullivan, President - Sales & Marketing chez National CineMedia (NCMI), a vendu 734 actions ordinaires NCMI le 08/21/2025 à 4,19 $ l'action dans le cadre d'un plan de négociation 10b5-1 préétabli adopté le 05/22/2025. Après la vente, elle détenait à titre bénéficiaire 23,535 actions. Le Formulaire 4 a été signé par un mandataire le 08/25/2025.

Catherine Sullivan, President - Sales & Marketing bei National CineMedia (NCMI), verkaufte am 08/21/2025 im Rahmen eines vorab festgelegten 10b5-1-Handelsplans, der am 05/22/2025 angenommen wurde, 734 Stammaktien von NCMI zum Preis von $4.19 je Aktie. Nach dem Verkauf war sie wirtschaftlich berechtigt an 23,535 Aktien. Das Formular 4 wurde am 08/25/2025 von einem Bevollmächtigten unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sullivan Catherine

(Last) (First) (Middle)
C/O NATIONAL CINEMEDIA, INC.
6300 S. SYRACUSE WAY

(Street)
CENTENNIAL CO 80111

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
National CineMedia, Inc. [ NCMI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President - Sales & Marketing
3. Date of Earliest Transaction (Month/Day/Year)
08/21/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/21/2025 S 734 D $4.19 23,535 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
The reported transaction is an open market sale made pursuant to a 10b5-1 trading plan adopted by the reporting person on May 22, 2025.
/s/ Laura Anne Kenwick, as attorney-in-fact 08/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did NCMI insider Catherine Sullivan sell according to the Form 4?

She sold 734 shares of National CineMedia common stock on 08/21/2025 at $4.19 per share.

Was the sale part of a planned trading arrangement for NCMI (ticker: NCMI)?

Yes. The sale was executed pursuant to a 10b5-1 trading plan adopted by the reporting person on May 22, 2025.

How many NCMI shares did Catherine Sullivan own after the reported transaction?

After the sale she beneficially owned 23,535 shares.

Who signed the Form 4 for the NCMI filing and when?

The Form 4 was signed by Laura Anne Kenwick, as attorney-in-fact, dated 08/25/2025.

Does the Form 4 indicate any derivative transactions for NCMI?

No. The filing contains no entries in Table II for derivative securities; only a non-derivative sale is reported.
National Cinemedia Inc

NASDAQ:NCMI

NCMI Rankings

NCMI Latest News

NCMI Latest SEC Filings

NCMI Stock Data

419.82M
92.65M
1.13%
89.3%
7.81%
Advertising Agencies
Services-advertising
Link
United States
CENTENNIAL